Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
Tepper SJ, Cady RK, Silberstein S, Messina J, Mahmoud RA, Djupesland PG, Shin P, Siffert J. Tepper SJ, et al. Among authors: djupesland pg. Headache. 2015 May;55(5):621-35. doi: 10.1111/head.12583. Epub 2015 May 4. Headache. 2015. PMID: 25941016 Free PMC article. Clinical Trial.
NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps.
Sindwani R, Han JK, Soteres DF, Messina JC, Carothers JL, Mahmoud RA, Djupesland PG. Sindwani R, et al. Among authors: djupesland pg. Am J Rhinol Allergy. 2019 Jan;33(1):69-82. doi: 10.1177/1945892418810281. Epub 2018 Nov 27. Am J Rhinol Allergy. 2019. PMID: 30477309 Free PMC article. Clinical Trial.
Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial.
Quintana DS, Westlye LT, Hope S, Nærland T, Elvsåshagen T, Dørum E, Rustan Ø, Valstad M, Rezvaya L, Lishaugen H, Stensønes E, Yaqub S, Smerud KT, Mahmoud RA, Djupesland PG, Andreassen OA. Quintana DS, et al. Among authors: djupesland pg. Transl Psychiatry. 2017 May 23;7(5):e1136. doi: 10.1038/tp.2017.103. Transl Psychiatry. 2017. PMID: 28534875 Free PMC article. Clinical Trial.
Low-dose intranasal oxytocin delivered with Breath Powered device modulates pupil diameter and amygdala activity: a randomized controlled pupillometry and fMRI study.
Quintana DS, Westlye LT, Alnæs D, Kaufmann T, Mahmoud RA, Smerud KT, Djupesland PG, Andreassen OA. Quintana DS, et al. Among authors: djupesland pg. Neuropsychopharmacology. 2019 Jan;44(2):306-313. doi: 10.1038/s41386-018-0241-3. Epub 2018 Oct 16. Neuropsychopharmacology. 2019. PMID: 30323359 Free PMC article. Clinical Trial.
71 results